JSK Investments fund invested in US startup Andromeda Surgical, which is developing an autonomous surgical platform with AI
The Kijonka couple’s JSK Investments fund invested single-digit millions of dollars in the US startup Andromeda Surgical, which is developing an autonomous surgical platform with AI. The startup is now entering the commercial phase and has raised a total of 30 million dollars.
The Kijonka couple’s investment fund JSK Investments invested single-digit millions of dollars in Andromeda Surgical, a US startup based in San Francisco, as part of a Series A funding round. Andromeda is developing an autonomous surgical platform using machine learning, with the aim of teaching robots to perform surgical procedures without the need for direct intervention by a doctor.
The company was founded in 2023 by Nick Damiano and Kartik Tiwari, who met at the Y Combinator incubator. According to the source, Damiano has experience developing healthcare technologies and is behind three companies operating in thousands of healthcare facilities. Tiwari brings experience from the autonomous vehicle sector as a co-founder of one of the pioneering startups focused on autonomous trucks.
The platform’s initial focus is the specialized urological procedure HoLEP. According to the source, the platform is intended to shorten surgeon training time and enable hospitals to offer specialized procedures even without a specialist in that specific field on site. Andromeda is now entering the commercial phase. The company raised 15 million dollars in the Series A round, bringing its total funding, including earlier investments, to 30 million dollars.
Commenting on the investment in Andromeda, Simona Kijonková said she had always believed in help from robots and AI, provided that control over them remained in human hands. The JSK fund previously invested in the startups Elin.AI and Kodu; according to the source, the investment in Andromeda is the fund’s first US investment in a field similar to that of an earlier investment in a company focused on smart breast examinations.
Why it matters
The investment demonstrates interest among European investment funds in US healthcare AI startups and shows how autonomous surgical platforms are moving from development to commercial deployment. According to the company, such technology could enable hospitals to offer specialized procedures even without a specialist in that specific field on site, which could affect the availability of some procedures.
Relevant practical impact
What this means
For a business
The Kijonka couple’s JSK Investments fund is expanding its investment portfolio to include US healthcare AI startups and entering the autonomous surgery segment, signaling where the fund is allocating capital outside the Czech Republic.
StrategyCheck the original
Event sources
only one source so far · 1 publisher, 1 independent. We count feeds from the same owner only once.